相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly et al.
BLOOD (2011)
Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia
Lubica Rauova et al.
BLOOD (2010)
Spleen tyrosine kinases: biology, therapeutic targets and drugs
Mauro Riccaboni et al.
DRUG DISCOVERY TODAY (2010)
A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function
Herve Falet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
R. Lacroix et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk et al.
BLOOD (2009)
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcγRIIa and the integrin β3 cytoplasmic domain
Cunji Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Thrombin generation and heparin-induced thrombocytopenia
B. Tardy-Poncet et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Heparin-induced thrombocytopenia
A. Greinacher
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets
J. C. Spalton et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets
Brian Boylan et al.
BLOOD (2008)
Heparin-induced thrombocytopenia: a historical perspective
John G. Kelton et al.
BLOOD (2008)
Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation:: insights into the mechanism of PLCγ2 activation
Ashraf Ragab et al.
BLOOD (2007)
Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways
Brigitte Kasper et al.
JOURNAL OF IMMUNOLOGY (2007)
Platelet integrins and immunoreceptors
Ana Kasirer-Friede et al.
IMMUNOLOGICAL REVIEWS (2007)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Eptifibatide-induced thrombocytopenia and thrombosis
Slava Epelman et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Tissue factor in cardiovascular diseases -: Molecular mechanisms and clinical implications
J Steffel et al.
CIRCULATION (2006)
A new role for Fc gamma RIIA in the potentiation of human platelet activation induced by weak stimulation
I Canobbio et al.
CELLULAR SIGNALLING (2006)
GPVI and integrin αIIβ3 signaling in platelets
SP Watson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Heparin-induced thrombocytopenia and other immune thrombocytopenias: Lessons from mouse models
SE McKenzie et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
The pathophysiology of immune-mediated heparin-induced thrombocytopenia
RF Reilly
SEMINARS IN DIALYSIS (2003)
Insights from mouse models of heparin-induced thrombocytopenia and thrombosis
MP Reilly et al.
CURRENT OPINION IN HEMATOLOGY (2002)
Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton
A Obergfell et al.
JOURNAL OF CELL BIOLOGY (2002)
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA
MP Reilly et al.
BLOOD (2001)
Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8
GM Arepally et al.
BLOOD (2001)
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
C Pouplard et al.
BLOOD (2001)